Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 30,000 ONCY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/Award | 30,000 | n/a |
| May 1, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Feb 13, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase | 30,000 | $25.3K |
| Jan 9, 2026 | Altimmune, Inc. (ALT) | Purchase | 5,000 | $20.4K |
| Sep 29, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Sep 30, 2024 | Altimmune, Inc. (ALT) | Grant/Award | 34,900 | n/a |
| Sep 29, 2023 | Altimmune, Inc. (ALT) | Grant/Award | 26,100 | n/a |
| Dec 22, 2022 | Altimmune, Inc. (ALT) | Exercise/Conversion | 20,000 | $52.0K |
| Oct 1, 2022 | Altimmune, Inc. (ALT) | Grant/Award | 23,500 | n/a |
| Sep 25, 2021 | Altimmune, Inc. (ALT) | Grant/Award | 24,100 | n/a |